Glaxo asthma drug clears key hurdle in Europe – MarketWatch


Yahoo News

Glaxo asthma drug clears key hurdle in Europe
MarketWatch
LONDON–GlaxoSmithKline PLC's [GSK.LN] new severe-asthma medicine has received a positive opinion from the scientific committee of the European Medicines Agency for use in adults, clearing a key hurdle towards gaining marketing approval in Europe.
EU regulator backs approval for GSK injectable asthma drugYahoo News
GlaxoSmithKline plc (ADR) To Lead Asthma MarketBidness ETC
GlaxoSmithKline's asthma injection heads for EU approvalFierceBiotech

all 24 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.